HRT FINANCIAL LP

Position in ABBV — AbbVie Inc.

CIK 1475597 NEW YORK, NY

Position in ABBV

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$201,484,910

+$190,970,679 QoQ

Shares Held

926,410

+1940.1% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.87%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $579,743,845 across 13 Drug Manufacturers - General names. ABBV ranks #1 (34.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	926,410	$201,484,910
2	BMY	Bristol Myers Squibb Co	2,075,945	$125,906,064
3	AMGN	Amgen Inc	321,715	$113,195,422
4	LLY	ELI LILLY & Co	53,051	$48,794,718
5	GILD	Gilead Sciences, Inc.	270,699	$37,727,319
6	GSK	GSK plc	425,687	$23,493,665
7	MRK	Merck & Co., Inc.	142,729	$17,168,871
8	NVS	Novartis AG	24,886	$3,801,336

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$201,484,910	926,410	+1940.1%	Shares	Defined	2026-05-14
2025-09-30	$10,514,231	45,410	+833.0%	Shares	Defined	2025-11-14
2025-06-30	$903,412	4,867	-93.1%	Shares	Defined	2025-08-14
2025-03-31	$14,859,786	70,923	+188.1%	Shares	Defined	2025-05-15
2024-12-31	$4,374,263	24,616	-91.9%	Shares	Defined	2025-02-14
2024-09-30	$60,358,774	305,645	+61.2%	Shares	Defined	2024-11-12
2024-06-30	$32,515,217	189,571	+1989.4%	Shares	Defined	2024-08-12
2023-12-31	$1,406,042	9,073	-95.3%	Shares	Defined	2024-02-09
2023-06-30	$25,878,130	192,074	+346.9%	Shares	Defined	2023-08-11
2022-06-30	$6,583,123	42,982	-68.6%	Shares	Defined	2022-08-12
2021-06-30	$15,410,503	136,812	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.